Melanoma-reactive T cells in the bone marrow of melanoma patients: Association with disease stage and disease duration

Cancer Research

Volumn 66, Issue 12, 2006, Pages 5997-6001

  Müller Berghaus, Jan ^a   Ehlert, Katrin ^b   Ugurel, Selma ^a   Umansky, Viktor ^a   Bucur, Mariana ^b   Schirrmacher, Volker ^b   Beckhove, Philipp ^b   Schadendorf, Dirk ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DACARBAZINE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; IMATINIB; MELAN A; MELANOMA ANTIGEN 3; TEMOZOLOMIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW; CANCER CELL; CANCER STAGING; CANCER THERAPY; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE DURATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MELANOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; BONE MARROW CELLS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; T-LYMPHOCYTES;

EID: 33745714516     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0484     Document Type: Article

References (19)

1. Tripp RA, Topham DJ, Watson SR, Doherty PC. Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol 1997;158:3716-20.
2. Feuerer M, Beckhove P, Garbi N, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med 2003;9:1151-7.
3. Di Rosa F, Santoni A. Memory T-cell competition for bone marrow seeding. Immunology 2003;108:296-304.
4. Di Rosa F, Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol 2005;26:360-6.
5. Feuerer M, Beckhove P, Bai L, et al. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med 2001;7:452-8.
6. + T cells in patients with advanced melanoma. Int J Cancer 2000;87:659-64.
7. Meyers ML, Balch CM. Diagnosis and treatment of metastatic melanoma. In: S-J. Soong, editor. Cutaneous Melanoma. 3rd ed. St. Louis (MO): Quality Medical Publishing, Inc.; 1998. p. 325-72.
8. Schadendorf D, Dorn-Beineke A, Borelli S, Riethmuller G, Pantel K. Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients. Exp Dermatol 2003;12:165-71.
9. Ghossein RA, Bhattacharya S, Coit DG. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned? Recent Results Cancer Res 2001;158:63-77.
10. Faye RS, Aamdal S, Hoifodt HK, et al. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin Cancer Res 2004;10:4134-9.
11. + memory T cells. Cancer Res 2003;63:5582-6.
12. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
13. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976;17:565-77.
14. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance, and immunity. Annu Rev Immunol 2001;19:47-64.
15. Melief CJ, Van Der Burg SH, Toes RE, Ossendorp F, Offringa R. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev 2002;188:177-82.
16. Schmitz-Winnenthal FH, Volk C, Z'Graggen K, et al. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Res 2005;65:10079-87.
17. Pantel K, Muller V, Auer M, Nusser N, Harbeck N, Braun S. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. Clin Cancer Res 2003;9:6326-34.
18. Simmons R, Hoda S, Osborne M. Bone marrow micrometastases in breast cancer patients. Am J Surg 2000;180:309-12.
19. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001;291:2413-7.